Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.650
+0.020 (1.23%)
At close: Nov 13, 2026, 4:00 PM EST
1.670
+0.020 (1.24%)
After-hours: Nov 13, 2026, 7:19 PM EST
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $299.64 million as of November 13, 2026. It is the 17,951st most valuable company in the world and the 3,167th biggest in the United States. Its market cap has increased by 515.74% in one year.
Market Cap
299.64M
Enterprise Value
219.93M
1-Year Change
515.74%
Global Rank
Country Rank
#3,167 United States
Category
ChartMarket Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $299.64M, a decrease of -71.49%. That is a compound annual growth rate of -20.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 299.64M | 244.97% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agenus | 326.68M |
| Ocugen | 325.87M |
| Scribe Therapeutics | 319.19M |
| Kyverna Therapeutics | 316.64M |
| Vicore Pharma Holding AB | 316.52M |
| Turn Therapeutics | 314.86M |
| Evommune | 312.84M |
| Cabaletta Bio | 312.79M |